案例报告:在复发性和耐火性外骨髓性多发性骨髓瘤中,双重向的BCMA和CS1CAR-T细胞免疫疗法
Xiangjun Shi1, Yue Wu2, Xingchen Yao2
1Department of Rheumatology and Immunology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Frontiers in immunology
|August 14, 2024
概括
针对BCMA和CS1的CAR-T细胞疗法在治疗多发性骨髓瘤的外骨髓性复发时表现出有限的疗效. 瘤中MYBL2表达的增加可能会阻碍治疗的成功,这表明需要新的治疗策略.
科学领域:
- 血液学 血液学 血液学
- 免疫治疗是一种免疫疗法.
- 在瘤学瘤学.
背景情况:
- 化学抗原受体T细胞 (CAR-T) 免疫疗法改善了多发性骨髓瘤治疗.
- 目前的CAR-T战略针对的是BCMA,CS1,CD38,FcRH5和GPRC5D.
- 挑战包括抗原逃逸,有限的CAR-T细胞持久性和瘤微环境的复杂性,导致复发.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)

